Skip to main content

Colorectal Surgery

4
Pipeline Programs
5
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
4
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
2 programs
2
AlvimopanPhase 3
MK0826, ertapenem sodiumPhase 3
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
2 programs
2
AlvimopanPhase 3
MK0826, ertapenem sodiumPhase 3
Prescient Therapeutics
Prescient TherapeuticsAustralia - South Melbourne
1 program
CleanCision Wound Retraction and Protection SystemN/A1 trial
Active Trials
NCT03816995Completed702Est. Aug 2023
Edwards Lifesciences
1 program
ERAS perioperative careN/A1 trial
Active Trials
NCT03189550Completed664Est. Feb 2017
Exero Medical
Exero MedicalIsrael - Or Yehuda
1 program
xBar systemN/A1 trial
Active Trials
NCT06168669Recruiting190Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Exero MedicalxBar system
Prescient TherapeuticsCleanCision Wound Retraction and Protection System
Edwards LifesciencesERAS perioperative care

Clinical Trials (3)

Total enrollment: 1,556 patients across 3 trials

NCT06168669Exero MedicalxBar system

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

Start: Mar 2023Est. completion: Dec 2025190 patients
N/ARecruiting
NCT03816995Prescient TherapeuticsCleanCision Wound Retraction and Protection System

Prospective, Randomized, Parallel-arm Clinical Trial of CleanCision or Alexis O in Elective Colorectal Surgery

Start: Feb 2019Est. completion: Aug 2023702 patients
N/ACompleted
NCT03189550Edwards LifesciencesERAS perioperative care

Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project

Start: Jul 2014Est. completion: Feb 2017664 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 1,556 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.